394 related articles for article (PubMed ID: 32230926)
1. Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas.
Jacques C; Tesfaye R; Lavaud M; Georges S; Baud'huin M; Lamoureux F; Ory B
Cells; 2020 Mar; 9(4):. PubMed ID: 32230926
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
3. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
[TBL] [Abstract][Full Text] [Related]
4. The microRNA-29 plays a central role in osteosarcoma pathogenesis and progression.
Zhang W; Qian JX; Yi HL; Yang ZD; Wang CF; Chen JY; Wei XZ; Fu Q; Ma H
Mol Biol (Mosk); 2012; 46(4):622-7. PubMed ID: 23113351
[TBL] [Abstract][Full Text] [Related]
5. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms and microRNAs in Osteosarcoma Pathogenesis.
Kushlinskii NE; Fridman MV; Braga EA
Biochemistry (Mosc); 2016 Apr; 81(4):315-28. PubMed ID: 27293089
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
9. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
[TBL] [Abstract][Full Text] [Related]
10. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
Elife; 2016 Apr; 5():. PubMed ID: 27070462
[TBL] [Abstract][Full Text] [Related]
11. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling.
Lengner CJ; Steinman HA; Gagnon J; Smith TW; Henderson JE; Kream BE; Stein GS; Lian JB; Jones SN
J Cell Biol; 2006 Mar; 172(6):909-21. PubMed ID: 16533949
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
13. Role of miR-142 in the pathogenesis of osteosarcoma and its potential as therapeutic approach.
Shabani P; Izadpanah S; Aghebati-Maleki A; Baghbani E; Baghbanzadeh A; Fotouhi A; Bakhshinejad B; Aghebati-Maleki L; Baradaran B
J Cell Biochem; 2019 Apr; 120(4):4783-4793. PubMed ID: 30450580
[TBL] [Abstract][Full Text] [Related]
14. MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.
Wang D; Tang L; Wu H; Wang K; Gu D
IUBMB Life; 2018 May; 70(5):411-419. PubMed ID: 29573114
[TBL] [Abstract][Full Text] [Related]
15. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834
[TBL] [Abstract][Full Text] [Related]
16. Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model.
Grilli A; Sciandra M; Terracciano M; Picci P; Scotlandi K
BMC Med Genomics; 2015 Jun; 8():34. PubMed ID: 26123714
[TBL] [Abstract][Full Text] [Related]
17. p53 transactivity during in vitro osteoblast differentiation in a rat osteosarcoma cell line.
Schwartz KA; Lanciloti NJ; Moore MK; Campione AL; Chandar N
Mol Carcinog; 1999 Jun; 25(2):132-8. PubMed ID: 10365915
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
Xie CH; Cao YM; Huang Y; Shi QW; Guo JH; Fan ZW; Li JG; Chen BW; Wu BY
Tumour Biol; 2016 Nov; 37(11):15031-15041. PubMed ID: 27658774
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle changes mediated by the p53/miR-34c axis are involved in the malignant transformation of human bronchial epithelial cells by benzo[a]pyrene.
Han Z; Zhang Y; Xu Y; Ji J; Xu W; Zhao Y; Luo F; Wang B; Bian Q; Liu Q
Toxicol Lett; 2014 Mar; 225(2):275-84. PubMed ID: 24362009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
